Construction of EIF4A3 shRNA lentiviral vector and establishment of its stable transfection cell line

Jiawen HE,You LI,Keqi LIAO,Shengnan LI

PDF(3574 KB)
PDF(3574 KB)
J Jilin Univ Med Ed ›› 2024, Vol. 50 ›› Issue (3) : 831-839. DOI: 10.13481/j.1671-587X.20240330
Methodology

Construction of EIF4A3 shRNA lentiviral vector and establishment of its stable transfection cell line

  • Jiawen HE1,2,You LI1,2(),Keqi LIAO2,Shengnan LI1,2()
Author information +
History +

Abstract

Objective To construct the eukaryotic cell translation initiation factor 4A3 (EIF4A3) short hairpin RNA (shRNA) lentiviral vector, and to establish the Neuro-2a-EIF4A3-shRNA stable transfection cell line. Methods The EIF4A3 gene sequence was retrieved from the National Center for Biotechnology Information (NCBI) database; the PCR identification primers were designed and synthesized, and connected to the lentiviral GV493 vector digested with EcoR I and Age I enzymes to construct the GV493-EIF4A3-shRNA lentiviral plasmid; PCR method was used to screen the positive clones, which were sequenced for the identification; the GV493 empty plasmid and GV493-EIF4A3-shRNA recombinant plasmid were transfected into the HEK293T cells, regarded as GV493 control lentivirus and GV493-EIF4A3-shRNA lentivirus, respectively. After 48 h of transfection, the lentiviruses were collected for packaging and the viral titer was determined. The Neuro-2a cells were divided into blank group, GV493 control group, and GV493-EIF4A3 shRNA group. The Neuro-2a cells in blank group were untreated, and the Neuro-2a cells in GV493 control group and GV493-EIF4A3 shRNA group were infected with the respective lentiviruses at a multiplicity of infection (MOI) of 100.The infected Neuro-2a cells were selected by 10 mg·L-1 puromycin, and the growth status and green fluorescence expression of the Neuro-2a cells in various groups were observed under fluorescence microscope; real-time fluorescence quantitative PCR (RT-qPCR) and Western blotting methods were used to detect the expression levels of EIF4A3 mRNA and protein in the Neuro-2a cells in various groups. Results The PCR sequencing results showed that the gene sequence of the GV493-EIF4A3-shRNA recombinant plasmid was consistent with the designed EIF4A3-shRNA sequence, indicating successful construction of the GV493-EIF4A3 lentiviral vector. The fluorescence microscope observation results showed that there was strong fluorescence expression and good growth status in the HEK293T cells, confirming successful lentiviral packaging. The viral titers for GV493 control lentivirus and GV493-EIF4A3-shRNA lentivirus both were 2×108 TU·mL-1. The growth status of the Neuro-2a cells in GV493 control group and GV493-EIF4A3 shRNA group was good, and they expressed green fluorescence, indicating successful construction of the stable transfection cell line. The RT-qPCR results showed that compared with blank group and GV493 control group, the expression level of EIF4A3 mRNA in the cells in GV493-EIF4A3 shRNA group was significantly decreased (P<0.01). The Western blotting results showed that the specific bands was at a relative molecular mass of 49 000, indicating successful EIF4A3 protein expression in the Neuro-2a cells. Compared with blank group and GV493 control group, the expression level of EIF4A3 protein in the cells in GV493-EIF4A3 shRNA group was significantly decreased (P<0.01). Conclusion The GV493-EIF4A3-shRNA lentiviral vector is succfssfully constructed, and the Neuro-2a-EIF4A3-shRNA stable transfection cell line is established; the results provide the reference for the study of the effect of EIF4A3 on the intracranial atherosclerosis.

Key words

Eukaryotic translation initiation factor 4A3 / Short hairpin RNA / Lentivirus / Stable transfection cell line / Neuro-2a cell

CLC number

R392

Cite this article

Download Citations
Jiawen HE,You LI,Keqi LIAO,Shengnan LI. Construction of EIF4A3 shRNA lentiviral vector and establishment of its stable transfection cell line. Journal of Jilin University(Medicine Edition). 2024, 50(3): 831-839 https://doi.org/10.13481/j.1671-587X.20240330

References

1 MCMAHON J J, MILLER E E, SILVER D L. The exon junction complex in neural development and neurodevelopmental disease[J]. Int J Dev Neurosci, 2016, 55: 117-123.
2 MAZLOOMIAN A, ARAKI S, OHORI M, et al. Pharmacological systems analysis defines EIF4A3 functions in cell-cycle and RNA stress granule formation[J]. Commun Biol, 2019, 2: 165.
3 FERRAIUOLO M A, LEE C S, LER L W, et al. A nuclear translation-like factor eIF4AⅢ is recruited to the mRNA during splicing and functions in nonsense-mediated decay[J]. Proc Natl Acad Sci U S A, 2004, 101(12): 4118-4123.
4 FUKAO A, MISHIMA Y, TAKIZAWA N, et al. MicroRNAs trigger dissociation of eIF4AⅠ and eIF4AⅡ from target mRNAs in humans[J]. Mol Cell, 2014, 56(1): 79-89.
5 GALICIA-VáZQUEZ G, CHU J, PELLETIER J. eIF4AⅡ is dispensable for miRNA-mediated gene silencing[J]. RNA, 2015, 21(10): 1826-1833.
6 WEI Y T, LU C F, ZHOU P, et al. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling[J]. Neuro Oncol, 2021, 23(4): 611-624.
7 YANG C J, HAWKINS K E, DORé S, et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke[J]. Am J Physiol Cell Physiol, 2019, 316(2): C135-C153.
8 LIU Y C, SONG J, ZHANG H W, et al. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway[J]. J Exp Clin Cancer Res, 2022, 41(1): 164.
9 ZHANG S X, LENG T Y, ZHANG Q, et al. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway[J]. Biomed Pharmacother, 2018, 102: 302-308.
10 SUI X Z, WANG Y C, LIU H. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression[J]. Mol Med Rep, 2021, 24(3): 654.
11 LAFFONT I, TAKAHASHI M, SHIBUKAWA Y, et al. Apolipoprotein E activates Akt pathway in neuro-2a in an isoform-specific manner[J]. Biochem Biophys Res Commun, 2002, 292(1): 83-87.
12 LI Y S, REN S H, XIA J W, et al. EIF4A3-induced circ-BNIP3 aggravated hypoxia-induced injury of H9c2 cells by targeting miR-27a-3p/BNIP3[J]. Mol Ther Nucleic Acids, 2020, 19: 533-545.
13 YU F P, ZHANG Y, WANG Z Z, et al. Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3[J]. Theranostics, 2021, 11(11): 5404-5417.
14 ZHANG M, ZHU Y Q, ZHU J, et al. circ_0086296 induced atherosclerotic lesions via the IFIT1/STAT1 feedback loop by sponging miR-576-3p[J]. Cell Mol Biol Lett, 2022, 27(1): 80.
15 RITZ K, DENSWIL N P, STAM O C G, et al. Cause and mechanisms of intracranial atherosclerosis[J]. Circulation, 2014, 130(16): 1407-1414.
16 WANG Y, MENG R, LIU G, et al. Intracranial atherosclerotic disease[J]. Neurobiol Dis, 2019, 124: 118-132.
17 XU S K, GE Y S, WANG X B, et al. Circ-USP9X interacts with EIF4A3 to promote endothelial cell pyroptosis by regulating GSDMD stability in atherosclerosis[J]. Clin Exp Hypertens, 2023, 45(1): 2186319.
18 YANG H Z, YANG W C, DAI W Q, et al. LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non-small cell lung cancer through stabilizing VEGFA by EIF4A3[J]. Cell Biol Int, 2020, 44(8): 1671-1680.
19 LAM M, SANOSAKA T, LUNDIN A, et al. Single-cell study of neural stem cells derived from human iPSCs reveals distinct progenitor populations with neurogenic and gliogenic potential[J]. Genes Cells, 2019, 24(12): 836-847.
20 MATSUI T K, TSURU Y, HASEGAWA K, et al. Vascularization of human brain organoids[J]. Stem Cells, 2021, 39(8): 1017-1024.

Comments

PDF(3574 KB)

Accesses

Citation

Detail

Sections
Recommended

/